Clinical Trial Detail

NCT ID NCT03047135
Title Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors
Indications

prostate adenocarcinoma

Therapies

Olaparib

Age Groups: adult senior

Additional content available in CKB BOOST